Paysign, Inc. (PAYS)
| Market Cap | 343.25M +208.4% |
| Revenue (ttm) | 82.03M +40.5% |
| Net Income | 7.55M +97.9% |
| EPS | 0.13 +85.7% |
| Shares Out | 55.19M |
| PE Ratio | 47.85 |
| Forward PE | 26.19 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 388,275 |
| Open | 6.10 |
| Previous Close | 6.09 |
| Day's Range | 5.90 - 6.22 |
| 52-Week Range | 2.19 - 8.88 |
| Beta | 0.64 |
| Analysts | Strong Buy |
| Price Target | 9.42 (+51.45%) |
| Earnings Date | May 12, 2026 |
About PAYS
Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. The company offers solutions for corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card and software s... [Read more]
Financial Performance
In 2025, Paysign's revenue was $82.03 million, an increase of 40.50% compared to the previous year's $58.38 million. Earnings were $7.55 million, an increase of 97.90%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for PAYS stock is "Strong Buy." The 12-month stock price target is $9.42, which is an increase of 51.45% from the latest price.
News
Paysign to Host First Quarter 2026 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host First Quarter 2026 Earnings Call.
Paysign Earnings Call Transcript: Q4 2025
Revenue grew 40.5% to $82M in 2025, with net income up 98% and strong margin expansion. Patient Affordability revenue surged 168%, and 2026 guidance calls for 30–35% growth, driven by both plasma and pharma segments.
Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results.
Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call.
Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference.
Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions.
Paysign Transcript: 17th Annual Southwest IDEAS Conference
Leadership with deep payments and banking expertise drives growth in patient affordability and plasma payment sectors. Proprietary technology and high client retention fuel strong financial performance, with revenue and margins rising year-over-year.
Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference.
Paysign Earnings Call Transcript: Q3 2025
Q3 2025 saw record revenue and profit growth, led by a 142% surge in patient affordability revenue and continued expansion in plasma. Guidance for 2025 was raised, with strong margin improvements and robust cash flow, despite plasma industry oversupply and regulatory delays for new tech platforms.
Paysign, Inc. Reports Third Quarter 2025 Financial Results
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Third Quarter 2025 Financial Results.
Paysign to Host Third Quarter 2025 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Third Quarter 2025 Earnings Call.
Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions.
Paysign, Inc. Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions
HENDERSON, Nev.--(BUSINESS WIRE)--Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions.
Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business.
Paysign, Inc. to Present at the Lake Street Best Ideas Growth BIG9 Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Lake Street Best Ideas Growth BIG9 Conference.
Paysign, Inc. Announces Election of Dan Henry as Chairman of the Board
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Announces Election of Dan Henry as Chairman of the Board.
Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference.
Paysign Earnings Call Transcript: Q2 2025
Record Q2 revenue rose 33% to $19.1M, driven by 190% growth in patient affordability, while plasma revenue declined 4.7% year-over-year but rebounded sequentially. 2025 guidance was raised, with strong margin expansion and robust program pipeline supporting continued growth.
Paysign, Inc. Reports Second Quarter 2025 Financial Results
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Second Quarter 2025 Financial Results.
Paysign to Host Second Quarter 2025 Earnings Call
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Second Quarter 2025 Earnings Call.
Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers.
Paysign, Inc. Awarded 132 Plasma Centers for Immediate Transition
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Awarded 132 Plasma Centers for Immediate Transition.
Paysign Transcript: The MicroCap Rodeo Conference - NYC
Paysign highlighted strong revenue growth, especially in patient affordability, and improved margins driven by technology and strategic acquisitions. Plasma business faces short-term headwinds, but investments and new software are expected to drive future growth.
Paysign, Inc. to Present at the MicroCap Rodeo Spring Conference
HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the MicroCap Rodeo Spring Conference.
PaySign Analysts Increase Their Forecasts After Better-Than-Expected Earnings
Paysign, Inc. posted stronger-than-expected earnings for the first quarter on Thursday.